Recombinant CD1b (T-Cell Surface Glycoprotein) Antibody [CD1B/16926R]

In Stock
Catalog Number Formulation Size Price
910-RBM4-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$259.00
910-RBM4-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$559.00
910-RBM4-P1ABX
Purified Ab WITHOUT BSA or Azide at 1.0mg/ml
100ug
$559.00
Flat Rate Domestic: $95 | Orders outside the US - Contact Us for Order Information | Ships next business day

Applications & Dilutions

Applications Tested Dillution Protocol
Western Blot (WB)
2-4ug/ml

Summary

Antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells.

Product Properties & Targets

Host
Rabbit
Applications
Species Reactivity
Isotype / Light Chain
IgG / Kappa
Cellular Localization
Cell membrane, Endosome membrane, Lysosome membrane
Gene Name
Positive Control
Expressed on cortical thymocytes, on certain T-cell leukemias, and in various other tissues
Immunogen
Recombinant full-length human CD1b protein
Alternate Names
T-cell surface glycoprotein CD1b, CD1|CD1A|R1

Database Links

Entrez Gene ID
910
SwissProt

Additional Information

Clone
CD1B/16926R
Chromosome Location
1q23.1
Mol. Weight of Antigen
36.94kDa
Expression System
CHO Cells
Purification
Protein A

Functions

  • Antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells.

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab produced in a mammalian-based expression system. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK